Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein

被引:3
|
作者
Tang, Xiao [1 ,2 ,3 ]
Liu, Yang [2 ,3 ]
Wang, Jinhui [2 ,3 ]
Long, Teng [4 ,5 ]
Mok, Bobo Wing Yee [4 ,5 ]
Huang, Yan [2 ,3 ]
Peng, Ziqing [2 ,3 ]
Jia, Qinyu [6 ,7 ]
Liu, Chengxi [6 ,7 ]
So, Pui-Kin [6 ,7 ]
Tse, Sirius Pui-Kam [6 ,7 ]
Liu, Shiyi [8 ]
Sun, Fei [9 ]
Tang, Shaojun [8 ]
Yao, Zhong-Ping [6 ]
Chen, Honglin [4 ,5 ]
Guo, Yusong [2 ,3 ,10 ]
机构
[1] Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Mol Enzymol & Mech Major Metab, Wuhu, Peoples R China
[2] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China
[3] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China
[5] Univ Hong Kong, Ctr Virol Vaccinol & Therapeut Ltd, Pokfulam, Hong Kong, Peoples R China
[6] Hong Kong Polytech Univ, Res Inst Future Food, Res Ctr Chinese Med Innovat, State Key Lab Chem Biol & Drug Discovery,Kowloon, Hong Kong, Peoples R China
[7] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China
[8] Hong Kong Univ Sci & Technol Guangzhou, Thrust Biosci & Biomed Engn, Guangzhou, Peoples R China
[9] Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Peoples R China
[10] Hong Kong Univ Sci & Technol, Shenzhen Res Inst, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
ENTRY; ADAM9;
D O I
10.1016/j.jbc.2024.107390
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 entry into host cells is facilitated by the interaction between the receptor-binding domain of its spike protein (CoV2-RBD) and host cell receptor, ACE2, promoting viral membrane fusion. The virus also uses endocytic pathways for entry, but the mediating host factors remain largely unknown. It is also unknown whether mutations in the RBD of SARSCoV-2 variants promote interactions with additional host factors to promote viral entry. Here, we used the GST pull-down approach to identify novel surface-located host factors that bind to CoV2-RBD. One of these factors, SH3BP4, regulates internalization of CoV2-RBD in an ACE2-independent but integrin- and clathrin-dependent manner and mediates SARSCoV-2 pseudovirus entry, suggesting that SH3BP4 promotes viral entry via the endocytic route. Many of the identified factors, including SH3BP4, ADAM9, and TMEM2, show stronger affinity to CoV2-RBD than to RBD of the less infective SARS-CoV, suggesting SARS-CoV-2-specific utilization. We also found factors preferentially binding to the RBD of the SARS-CoV-2 Delta variant, potentially enhancing its entry. These data identify the repertoire of host cell surface factors that function in the events leading to the entry of SARS-CoV-2.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
    Bozdaganyan, Marine E.
    Shaitan, Konstantin V.
    Kirpichnikov, Mikhail P.
    Sokolova, Olga S.
    Orekhov, Philipp S.
    VIRUSES-BASEL, 2022, 14 (02):
  • [42] Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain
    Sankhala, Rajeshwer S.
    Dussupt, Vincent
    Chen, Wei-Hung
    Bai, Hongjun
    Martinez, Elizabeth J.
    Jensen, Jaime L.
    Rees, Phyllis A.
    Hajduczki, Agnes
    Chang, William C.
    Choe, Misook
    Yan, Lianying
    Sterling, Spencer L.
    Swafford, Isabella
    Kuklis, Caitlin
    Soman, Sandrine
    King, Jocelyn
    Corbitt, Courtney
    Zemil, Michelle
    Peterson, Caroline E.
    Mendez-Rivera, Letzibeth
    Townsley, Samantha M.
    Donofrio, Gina C.
    Lal, Kerri G.
    Tran, Ursula
    Green, Ethan C.
    Smith, Clayton
    de Val, Natalia
    Laing, Eric D.
    Broder, Christopher C.
    Currier, Jeffrey R.
    Gromowski, Gregory D.
    Wieczorek, Lindsay
    Rolland, Morgane
    Paquin-Proulx, Dominic
    van Dyk, Dewald
    Britton, Zachary
    Rajan, Saravanan
    Loo, Yueh Ming
    McTamney, Patrick M.
    Esser, Mark T.
    Polonis, Victoria R.
    Michael, Nelson L.
    Krebs, Shelly J.
    Modjarrad, Kayvon
    Joyce, M. Gordon
    STRUCTURE, 2024, 32 (02) : 131 - 147.e7
  • [43] Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
    Antonopoulos, Aristotelis
    Broome, Steven
    Sharov, Victor
    Ziegenfuss, Christopher
    Easton, Richard L.
    Panico, Maria
    Dell, Anne
    Morris, Howard R.
    Haslam, Stuart M.
    GLYCOBIOLOGY, 2021, 31 (03) : 181 - 187
  • [44] Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
    Giovanni A. Rossi
    Oliviero Sacco
    Enrica Mancino
    Luca Cristiani
    Fabio Midulla
    Infection, 2020, 48 : 665 - 669
  • [45] Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
    Mehalko, Jennifer
    Drew, Matthew
    Snead, Kelly
    Denson, John-Paul
    Wall, Vanessa
    Taylor, Troy
    Sadtler, Kaitlyn
    Messing, Simon
    Gillette, William
    Esposito, Dominic
    PROTEIN EXPRESSION AND PURIFICATION, 2021, 179
  • [46] Peptide Binder with High-Affinity for the SARS-CoV-2 Spike Receptor-Binding Domain
    Yu, Lanlan
    Wang, Ruonan
    Wen, Tao
    Liu, Lei
    Wang, Tao
    Liu, Shuli
    Xu, Haiyan
    Wang, Chenxuan
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (25) : 28527 - 28536
  • [47] Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
    Rossi, Giovanni A.
    Sacco, Oliviero
    Mancino, Enrica
    Cristiani, Luca
    Midulla, Fabio
    INFECTION, 2020, 48 (05) : 665 - 669
  • [48] Infrared spectra of the SARS-CoV-2 spike receptor-binding domain: Molecular dynamics simulations
    Du, Jianbin
    Yao, Ning
    Ma, Xiangyun
    Wang, Huijie
    Li, Qifeng
    Feng, Zhifang
    CHEMICAL PHYSICS LETTERS, 2023, 810
  • [49] A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
    Sajjan Rajpoot
    Tomokazu Ohishi
    Ashutosh Kumar
    Qiuwei Pan
    Sreeparna Banerjee
    Kam Y. J. Zhang
    Mirza S. Baig
    Drugs in R&D, 2021, 21 : 273 - 283
  • [50] A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
    Rajpoot, Sajjan
    Ohishi, Tomokazu
    Kumar, Ashutosh
    Pan, Qiuwei
    Banerjee, Sreeparna
    Zhang, Kam Y. J.
    Baig, Mirza S.
    DRUGS IN R&D, 2021, 21 (03) : 273 - 283